Literature DB >> 22093646

Assisting people with disabilities to actively improve their collaborative physical activities with Nintendo Wii Balance Boards by controlling environmental stimulation.

Ching-Hsiang Shih1, Ling-Che Chen, Ching-Tien Shih.   

Abstract

The latest researches have adopted software technology to modify the Nintendo Wii Balance Board functionality and used it to enable two people with developmental disabilities to actively perform physical activities. This study extended the latest research of the Wii Balance Board application to assess whether four people (two groups) with developmental disabilities would be able to actively improve their physical activities collaboration--walking to the designated location following simple instructions, by controlling their favorite environmental stimulation through using three Nintendo Wii Balance Boards. We employed an A-B-A-B design, with A represented the baseline and B represented intervention phases. Data showed that both groups of participants significantly increased their collaborative target response (collaboratively performing designated physical activities) by activating the control system to produce their preferred environmental stimulation during the intervention phases. Practical and developmental implications of the findings are discussed.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22093646     DOI: 10.1016/j.ridd.2011.08.006

Source DB:  PubMed          Journal:  Res Dev Disabil        ISSN: 0891-4222


  2 in total

Review 1.  Programs Using Stimulation-Regulating Technologies to Promote Physical Activity in People With Intellectual and Multiple Disabilities: Scoping Review.

Authors:  Giulio E Lancioni; Nirbhay N Singh; Mark O'Reilly; Jeff Sigafoos; Gloria Alberti; Lorenzo Desideri
Journal:  JMIR Rehabil Assist Technol       Date:  2022-04-07

2.  Active video games to promote physical activity in children with cancer: a randomized clinical trial with follow-up.

Authors:  Lotta Kauhanen; Liisa Järvelä; Päivi M Lähteenmäki; Mikko Arola; Olli J Heinonen; Anna Axelin; Johan Lilius; Tero Vahlberg; Sanna Salanterä
Journal:  BMC Pediatr       Date:  2014-04-05       Impact factor: 2.125

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.